×
About 161,650 results

ALLMedicine™ Colorectal Cancer Center

Research & Reviews  76,269 results

Are developmentally missing teeth a predictive risk marker of malignant diseases in non...
https://doi.org/10.1177/1465312520984166
Journal of Orthodontics; Al-Muzian L, Almuzian M et. al.

Jan 18th, 2021 - Different genes and loci that are associated with non-syndromic developmental tooth agenesis (TA) have the same causation pathway in the development of tumours including breast cancer (BC), epithelial ovarian cancer (EOC), colorectal cancer (CRC) ...

One negative colonoscopy associated with a significant reduction in colorectal cancer r...
https://doi.org/10.1002/cncr.33230
Cancer Reference; Printz C

Jan 18th, 2021 - One negative colonoscopy associated with a significant reduction in colorectal cancer risk.|2021|Printz C,|

N6-methyladenosine as a biological and clinical determinant in colorectal cancer: progr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806471
Theranostics Li J, Liang L et. al.

Jan 18th, 2021 - Colorectal cancer (CRC) is one of the most prevalent cancers and one of the leading causes of cancer death. Recent studies have provided evidence that N6-methyladenosine (m6A), the most abundant RNA modifications in eukaryote, performs many functi...

CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806482
Theranostics Feng W, Huang W et. al.

Jan 18th, 2021 - Background: Metastasis is the major reason for the high mortality of colorectal cancer (CRC). However, the molecular mechanism underlying CRC metastasis remains unclear. Here, we report a novel role of homeobox B5 (HOXB5), a member of the HOX fami...

Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806468
Theranostics Liu C, Wang L et. al.

Jan 18th, 2021 - Introduction: Serine hydroxymethyltransferase 2 (SHMT2) plays a critical role in serine-glycine metabolism to drive cancer cell proliferation. However, the nonmetabolic function of SHMT2 in tumorigenesis, especially in human colorectal cancer (CRC...

see more →

Guidelines  419 results

Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recom...
https://doi.org/10.14309/ajg.0000000000001013
The American Journal of Gastroenterology; Shaukat A, Kaltenbach T et. al.

Nov 6th, 2020 - Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.|2020|Shaukat A,Kaltenbach T,Dominitz JA,Robertson DJ,Anderson JC,|diagnosis,pathology,surger...

Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population
https://gut.bmj.com/content/early/2020/09/08/gutjnl-2020-320990
Gut Chapelle N

Sep 27th, 2020 - This review evaluates the evidence across 80 meta-analyses of interventional and observational studies of CRC prevention using medications, vitamins, supplements and dietary factors.

Clinical Implications of First-Line Pembro for MSI-High mCRC
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200220/full/

Jun 23rd, 2020 - Long-awaited results from the randomized, phase III KEYNOTE-177 trial provide strong support for using single-agent pembrolizumab instead of a chemotherapy-based regimen in patients newly diagnosed with metastatic colorectal cancer (mCRC) featurin...

Thierry André, MD, on Colorectal Cancer: Pembrolizumab vs Chemotherapy for Metastatic Disease
https://ascopost.com/videos/asco20-virtual-scientific-program/thierry-andre-on-pembrolizumab-vs-chemotherapy-for-metastatic-colorectal-cancer/

May 31st, 2020 - Thierry André, MD, of Hôpital Saint-Antoine, discusses the phase III results from KEYNOTE-177, which showed that, compared with standard chemotherapy of FOLFOX or FOLFIRI, pembrolizumab doubled median progression-free survival, from 8.2 months to...

Scott Kopetz, MD, PhD, on Colorectal Cancer: Encorafenib Plus Cetuximab With or Without Binimetinib
https://ascopost.com/videos/asco20-virtual-scientific-program/scott-kopetz-on-encorafenib-plus-cetuximab-with-or-without-binimetinib-in-colorectal-cancer/

May 29th, 2020 - Scott Kopetz, MD, PhD, of The University of Texas MD Anderson Cancer Center, discusses phase III results of the BEACON CRC study, which confirmed that, compared with standard chemotherapy, encorafenib plus cetuximab with or without binimetinib imp...

see more →

Drugs  213 results see all →

Clinicaltrials.gov  80,755 results

Are developmentally missing teeth a predictive risk marker of malignant diseases in non...
https://doi.org/10.1177/1465312520984166
Journal of Orthodontics; Al-Muzian L, Almuzian M et. al.

Jan 18th, 2021 - Different genes and loci that are associated with non-syndromic developmental tooth agenesis (TA) have the same causation pathway in the development of tumours including breast cancer (BC), epithelial ovarian cancer (EOC), colorectal cancer (CRC) ...

One negative colonoscopy associated with a significant reduction in colorectal cancer r...
https://doi.org/10.1002/cncr.33230
Cancer Reference; Printz C

Jan 18th, 2021 - One negative colonoscopy associated with a significant reduction in colorectal cancer risk.|2021|Printz C,|

N6-methyladenosine as a biological and clinical determinant in colorectal cancer: progr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806471
Theranostics Li J, Liang L et. al.

Jan 18th, 2021 - Colorectal cancer (CRC) is one of the most prevalent cancers and one of the leading causes of cancer death. Recent studies have provided evidence that N6-methyladenosine (m6A), the most abundant RNA modifications in eukaryote, performs many functi...

CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806482
Theranostics Feng W, Huang W et. al.

Jan 18th, 2021 - Background: Metastasis is the major reason for the high mortality of colorectal cancer (CRC). However, the molecular mechanism underlying CRC metastasis remains unclear. Here, we report a novel role of homeobox B5 (HOXB5), a member of the HOX fami...

Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806468
Theranostics Liu C, Wang L et. al.

Jan 18th, 2021 - Introduction: Serine hydroxymethyltransferase 2 (SHMT2) plays a critical role in serine-glycine metabolism to drive cancer cell proliferation. However, the nonmetabolic function of SHMT2 in tumorigenesis, especially in human colorectal cancer (CRC...

see more →

News  3,929 results

CRC Risk in Young Adults: Not as High as Previously Reported
https://www.medscape.com/viewarticle/943442

Dec 30th, 2020 - The risk for colorectal cancer (CRC) in young adults is actually lower than has been estimated, because previous studies did not differentiate between colorectal adenocarcinoma and the histologically different carcinoid tumors, which are incidenta...

Colorectal Cancer Risk in Men and Women is Based on Different Adiposity Measures
https://www.medscape.com/viewarticle/943036

Dec 21st, 2020 - A new study co-funded by the World Cancer Research Fund, Cancer Research UK and Diabetes UK suggests that colorectal cancer (CRC) risk in men and women may differ based on how the body fat is positioned. The findings were published in  BMC Medicin...

How to Stop Young Black Men From Dying of Colorectal Cancer
https://www.medscape.com/viewarticle/942812

Dec 17th, 2020 - The recent death of Today anchor Craig Melvin's brother from colorectal cancer (CRC) at 43 years old comes not long after actor Chadwick Boseman's death from CRC at the same age. In the wake of Boseman's death, oncologist David Kerr spoke about di...

Patients With Lung and Blood Cancers Most Vulnerable to COVID-19
https://www.medscape.com/viewarticle/942430

Dec 9th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Patients with cancer are at significantly increased risk for COVID-19 and worse outcomes, a new review confirms. It also found that patients with ...

Pembrolizumab 'Preferred Choice' in MSI-H/dMMR Metastatic CRC
https://www.medscape.com/viewarticle/941870

Dec 1st, 2020 - Frontline pembrolizumab (Keytruda) significantly improved progression-free survival (PFS) compared with chemotherapy among patients with microsatellite instability–high/mismatch repair–deficient (MSI-H/dMMR) metastatic colorectal cancer, according...

see more →

Patient Education  65 results see all →